Herpesvirus telomerase rna(vtr)-dependent lymphoma formation does not require interaction of vtr with telomerase reverse transcriptase (tert)

PLoS Pathogens

Volumn 6, Issue 8, 2010, Pages 87-88

  Kaufer, Benedikt B ^a   Trapp, Sascha ^a   Jarosinski, Keith W ^a   Osterrieder, Nikolaus ^a,b  

^a Cornell University ^*  (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERPESVIRUS TELOMERASE RNA; RIBOSOME PROTEIN; RIBOSOME PROTEIN RPL22; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; RNA; TELOMERASE RNA; VIRUS RNA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOMA; MARDIVIRUS; MAREK DISEASE; METASTASIS; NONHUMAN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TUMOR CELL; VIRUS REPLICATION; ANIMAL; CELL TRANSFORMATION; CHICKEN; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; PATHOLOGY;

ANIMALIA; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

ANIMALS; CATALYTIC DOMAIN; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; HERPESVIRUS 2, GALLID; MAREK DISEASE; MUTATION; RNA; RNA, VIRAL; TELOMERASE;

EID: 77958116945     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001073     Document Type: Article

References (41)

1. Greider CW, Blackburn EH (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51: 887-898.
2. Fragnet L, Blasco MA, Klapper W, Rasschaert D (2003) The RNA subunit of telomerase is encoded by Marek's disease virus. J Virol 77: 5985-5996.
3. Chen JL, Opperman KK, Greider CW (2002) A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res 30: 592-597.
4. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, et al. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
5. Ueda CT, Roberts RW (2004) Analysis of a long-range interaction between conserved domains of human telomerase RNA. RNA 10: 139-147.
6. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
7. Blasco MA (2002) Telomerase beyond telomeres. Nat Rev Cancer 2: 627-633.
8. Bellon M, Nicot C (2008) Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst 100: 98-108.
9. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N (2006) Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev Vaccines 5: 761-772.
10. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S (2006) Marek's disease virus: from miasma to model. Nat Rev Microbiol 4: 283-294.
11. Casillas MA, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO (2003) Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316: 57-65.
12. Kishi M, Bradley G, Jessip J, Tanaka A, Nonoyama M (1991) Inverted repeat regions of Marek's disease virus DNA possess a structure similar to that of the a sequence of herpes simplex virus DNA and contain host cell telomere sequences. J Virol 65: 2791-2797.
13. Fragnet L, Kut E, Rasschaert D (2005) Comparative functional study of the viral telomerase RNA based on natural mutations. J Biol Chem 280: 23502-23515.
14. Trapp S, Parcells MS, Kamil JP, Schumacher D, Tischer BK, et al. (2006) A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med 203: 1307-1317.
15. Li S, Crothers J, Haqq CM, Blackburn EH (2005) Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280: 23709-23717.
16. Blasco MA, Rizen M, Greider CW, Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12: 200-204.
17. Kedde M, le Sage C, Duursma A, Zlotorynski E, van Leeuwen B, et al. (2006) Telomerase-independent regulation of ATR by human telomerase RNA. J Biol Chem 281: 40503-40514.
18. Kim H, You S, Kim IJ, Foster LK, Farris J, et al. (2001) Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts. Oncogene 20: 2671-2682.
19. Le S, Sternglanz R, Greider CW (2000) Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell 11: 999-1010.
20. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, et al. (2007) Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759-772.
21. Murre C (2007) Ribosomal proteins and the control of alphabeta T lineage development. Immunity 26: 751-752.
22. Houmani JL, Davis CI, Ruf IK (2009) Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding. J Virol 83: 9844-9853.
23. Toczyski DP, Steitz JA (1991) EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J 10: 459-466.
24. Maesawa C, Inaba T, Sato H, Iijima S, Ishida K, et al. (2003) A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance. Nucleic Acids Res 31: E4.
25. Petherbridge L, Brown AC, Baigent SJ, Howes K, Sacco MA, et al. (2004) Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78: 13376-13380.
26. Tischer BK, von Einem J, Kaufer B, Osterrieder N (2006) Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipu-lation in Escherichia coli. Biotechniques 40: 191-197.
27. Shkreli M, Dambrine G, Soubieux D, Kut E, Rasschaert D (2007) Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis. J Virol 81: 4848-4857.
28. Herbert BS, Hochreiter AE, Wright WE, Shay JW (2006) Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc 1: 1583-1590.
29. Parcells MS, Dienglewicz RL, Anderson AS, Morgan RW (1999) Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J Virol 73: 1362-1373.
30. Fok V, Mitton-Fry RM, Grech A, Steitz JA (2006) Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12: 872-882.
31. Shu-Nu C, Lin CH, Lin A (2000) An acidic amino acid cluster regulates the nucleolar localization and ribosome assembly of human ribosomal protein L22. FEBS Lett 484: 22-28.
32. Calnek BW, Shek WR, Schat KA (1981) Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines. Infect Immun 34: 483-491.
33. Calnek BW, Murthy KK, Schat KA (1978) Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas. Int J Cancer 21: 100-107.
34. Pratt WD, Morgan R, Schat KA (1992) Cell-mediated cytolysis of lymphoblastoid cells expressing Marek's disease virus-specific phosphorylated polypeptides. Vet Microbiol 33: 93-99.
35. Osterrieder N (1999) Sequence and initial characterization of the U(L)10 (glycoprotein M) and U(L)11 homologous genes of serotype 1 Marek's Disease Virus. Arch Virol 144: 1853-1863.
36. Jarosinski KW, Margulis NG, Kamil JP, Spatz SJ, Nair VK, et al. (2007) Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J Virol 81: 10575-10587.
37. Schumacher D, Tischer BK, Fuchs W, Osterrieder N (2000) Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol 74: 11088-11098.
38. Schumacher D, Tischer BK, Trapp S, Osterrieder N (2005) The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J Virol 79: 3987-3997.
39. Jarosinski K, Kattenhorn L, Kaufer B, Ploegh H, Osterrieder N (2007) A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc Natl Acad Sci U S A 104: 20025-20030.
40. Jarosinski KW, Osterrieder N, Nair VK, Schat KA (2005) Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol 79: 11647-11659.
41. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, et al. (2002) A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99: 7877-7882.